Cellivery ranked among the top searched stocks for 3 days in the past month.

As of 2:30 PM on the 14th, Cellivery is trading at 136,300 KRW, up 7.32% from the previous day. This marks a 39.65% increase compared to July 17.

Today, foreigners are tentatively recorded as net sellers of 8,000 shares. Over the past 5 days, individual investors have net sold 4,714 shares, while foreigners and institutions have net bought 15,378 shares and 585 shares, respectively.

On August 13, Cellivery made headlines in the market with the announcement, "Producing capsule-type obesity treatment to compete with Saxenda, a 1 trillion KRW sales obesity drug..."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


Hot Picks Today

"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ① "Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①

한글 기사 보기
This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing